Financial reports
10-K
2023 FY
Annual report
14 Mar 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
10-K
2022 FY
Annual report
15 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
24 Feb 22
10-Q
2021 Q3
Quarterly report
4 Nov 21
Current reports
8-K
Vaxart Provides Business Update and Reports Full Year 2023 Financial Results
14 Mar 24
8-K
Vaxart, Inc. Appoints Steven Lo as New President, Chief Executive Officer, and Director
6 Mar 24
8-K
Departure of Directors or Certain Officers
29 Feb 24
8-K
Other Events
15 Feb 24
8-K/A
Departure of Directors or Certain Officers
2 Feb 24
8-K
Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
19 Jan 24
8-K
Vaxart Announces $10.0 Million Registered Direct Offering with RA Capital Management
16 Jan 24
8-K
Vaxart, Inc. Announces Management Change
16 Jan 24
8-K
Vaxart Provides Business Update and Reports Third Quarter 2023 Financial Results
2 Nov 23
8-K/A
Submission of Matters to a Vote of Security Holders
23 Oct 23
Registration and prospectus
S-8
Registration of securities for employees
14 Mar 24
424B5
Prospectus supplement for primary offering
17 Jan 24
424B5
Prospectus supplement for primary offering
8 Jun 23
424B5
Prospectus supplement for primary offering
6 Jun 23
424B5
Prospectus supplement for primary offering
9 May 23
S-3
Shelf registration
17 Mar 23
S-8
Registration of securities for employees
21 Oct 22
424B5
Prospectus supplement for primary offering
16 Sep 21
424B5
Prospectus supplement for primary offering
15 Sep 21
S-8
Registration of securities for employees
21 Jun 21
Proxies
PRE 14A
Preliminary proxy
18 Apr 24
DEFA14A
Additional proxy soliciting materials
21 Jun 23
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
26 Jul 22
DEFA14A
Additional proxy soliciting materials
26 Jul 22
DEFA14A
Additional proxy soliciting materials
12 Jul 22
DEFA14A
Additional proxy soliciting materials
1 Jul 22
DEFA14A
Additional proxy soliciting materials
1 Jul 22
DEFA14A
Additional proxy soliciting materials
24 Jun 22
Other
EFFECT
Notice of effectiveness
8 May 23
CORRESP
Correspondence with SEC
3 May 23
UPLOAD
Letter from SEC
23 Mar 23
UPLOAD
Letter from SEC
29 Jan 21
CORRESP
Correspondence with SEC
27 Jan 21
UPLOAD
Letter from SEC
22 Jan 21
CORRESP
Correspondence with SEC
8 Jan 21
UPLOAD
Letter from SEC
28 Dec 20
SEC STAFF
SEC staff action: Order
18 Feb 20
SEC STAFF
SEC staff action: Order
6 Feb 20